Dr. Holodniy is Professor of Medicine (Infectious Diseases & Geographic Medicine) at Stanford University and has been a full time employee of the Department of Veterans Affairs (VA) for over 25 years. He has been national director of Public Health Surveillance and Research (PHSR) in VA since 1999, which is a national program office based at the VA Palo Alto Health Care System (VAPAHCS). His current VA responsibilities include public health surveillance, conducting outbreak and large-scale lookback investigations within VA, and directing the VA Public Health Reference Laboratory (PHRL). PHRL is a national VA laboratory, aligned with CDC and the Laboratory Response Network (LRN), which supports clinical care and public health investigations utilizing state-of-the-art diagnostic microbiology methods and equipment. He also serves as the hospital epidemiologist and staff infectious disease physician for the VAPAHCS. Previously, he directed pharmacy services at the VAPAHCS from 1996-1999, the HIV clinical program at VAPAHCS from 1991-2011, and was the acting director of the VA Cooperative Studies Program Coordinating Center at VAPAHCS from 2007-2009, where he oversaw a portfolio of several multicenter VA studies and the VA DNA Bank Genomics Program.

His research program focuses on viral evolution, microbial development of drug resistance, clinical trial evaluation of novel diagnostics and antimicrobial compounds, and evaluation of clinical outcomes associated with infectious diseases. In that capacity, Dr. Holodniy has overseen the conduct of over 80 clinical and diagnostic assay trials at VAPAHCS since 1991. He has also mentored many infectious disease fellows, graduate students, and Epidemic Intelligence Service (EIS) officers, in collaboration with CDC.

Paul graduated from Columbia University Medical School in New York, completed residency and chief residency in pediatrics at the University of California, San Francisco, received a Masters of Public Health from University of California, Berkeley and completed a fellowship in health services research at Stanford University.

Paul is presently a Professor of Pediatrics at Stanford University, a pediatric hospitalist, and is the creator and Medical Director of the LPCH Center for Quality and Clinical Effectiveness and Chief Clinical Patient Safety Officer at Lucile Packard Children’s Hospital. Paul is presently the Director of Quality Improvement for the California Perinatal Quality of Care Collaborative (CPQCC), is a founding and current member of the Solutions for Patient Safety Clinical Steering Committee, and is on the Strategic Planning Committee for Quality and Patient Safety for CHA (Children’s Hospital Association). In 2013, Paul was awarded the inaugural Paul V. Miles Fellow in Quality Improvement from the American Board of Pediatrics, an Award bestowed on individuals who have “dedicated themselves to quality improvement and demonstrated accomplishments leading to better healthcare for children”. Paul is presently an investigator or co-investigator on numerous grants focused on pediatric patient safety. Most recently, Paul has dedicated his research and administrative efforts to translating the tenets of high reliability organization theory into healthcare, and is partnering with human factors engineers to translate “design thinking” into the healthcare industry to accelerate patient safety and quality improvement. Paul has given a substantial number of presentations at national and international academic meetings related to quality of care and patient safety and is a faculty member of the Institute for Healthcare Improvement (IHI). Paul has been a visiting professor on quality/patient safety at numerous children’s hospitals across the world including Great Ormond Street Hospital for Children in London, The Hospital for Sick Kids in Toronto, The Children’s Hospital of Eastern Ontario in Ottawa, and several national children’s hospitals including, Children’s National Hospital in Washington DC, Morgan Stanley Children’s Hospital of Columbia University, Children’s Hospital of Los Angeles, Children’s Hospital of Colorado, St Louis Children’s Hospital, Nationwide Children’s Hospital, and St Jude Children’s Research Hospital. Paul has published extensively on the topics of pediatric quality of care and patient safety, including a Nov 2007 study correlating a Rapid Response Team intervention with decreased mortality in JAMA, and a Nov 2010 study on adverse events over time in the New England Journal of Medicine, and is recognized internationally as a thought leader in the area of pediatric quality and patient safety.

Jeremy Goldhaber-Fiebert, PhD, is a Professor of Health Policy, a Core Faculty Member at the Center for Health Policy and the Department of Health Policy, and a Faculty Affiliate of the Stanford Center on Longevity and Stanford Center for International Development. His research focuses on complex policy decisions surrounding the prevention and management of increasingly common, chronic diseases and the life course impact of exposure to their risk factors. In the context of both developing and developed countries including the US, India, China, and South Africa, he has examined chronic conditions including type 2 diabetes and cardiovascular diseases, human papillomavirus and cervical cancer, tuberculosis, and hepatitis C and on risk factors including smoking, physical activity, obesity, malnutrition, and other diseases themselves. He combines simulation modeling methods and cost-effectiveness analyses with econometric approaches and behavioral economic studies to address these issues. Dr. Goldhaber-Fiebert graduated magna cum laude from Harvard College in 1997, with an A.B. in the History and Literature of America. After working as a software engineer and consultant, he conducted a year-long public health research program in Costa Rica with his wife in 2001. Winner of the Lee B. Lusted Prize for Outstanding Student Research from the Society for Medical Decision Making in 2006 and in 2008, he completed his PhD in Health Policy concentrating in Decision Science at Harvard University in 2008. He was elected as a Trustee of the Society for Medical Decision Making in 2011.

Past and current research topics:

1. Type 2 diabetes and cardiovascular risk factors: Randomized and observational studies in Costa Rica examining the impact of community-based lifestyle interventions and the relationship of gender, risk factors, and care utilization.
2. Cervical cancer: Model-based cost-effectiveness analyses and costing methods studies that examine policy issues relating to cervical cancer screening and human papillomavirus vaccination in countries including the United States, Brazil, India, Kenya, Peru, South Africa, Tanzania, and Thailand.
3. Measles, haemophilus influenzae type b, and other childhood infectious diseases: Longitudinal regression analyses of country-level data from middle and upper income countries that examine the link between vaccination, sustained reductions in mortality, and evidence of herd immunity.
4. Patient adherence: Studies in both developing and developed countries of the costs and effectiveness of measures to increase successful adherence. Adherence to cervical cancer screening as well as to disease management programs targeting depression and obesity is examined from both a decision-analytic and a behavioral economics perspective.
5. Simulation modeling methods: Research examining model calibration and validation, the appropriate representation of uncertainty in projected outcomes, the use of models to examine plausible counterfactuals at the biological and epidemiological level, and the reflection of population and spatial heterogeneity.